Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 3
1978 5
1980 3
1981 8
1982 4
1983 10
1984 12
1985 7
1986 8
1987 16
1988 9
1989 4
1990 4
1991 5
1992 9
1993 4
1994 9
1995 6
1996 16
1997 12
1998 15
1999 11
2000 13
2001 10
2002 6
2003 13
2004 5
2005 18
2006 5
2007 6
2008 9
2009 13
2010 11
2011 6
2012 6
2013 8
2014 10
2015 16
2016 10
2017 6
2018 8
2019 7
2020 6
2021 4
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

357 results

Results by year

Filters applied: . Clear all
Page 1
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).
Josefsson A, Jellvert Å, Holmberg E, Brasso K, Meidahl Petersen P, Aaltomaa S, Luukkaa M, Verhagen P, de Wit R, Ahlgren G, Andrén O, Castellanos E, Seke M, Widmark A, Damber JE; SPCG14-investigators. Josefsson A, et al. Among authors: damber je. Acta Oncol. 2023 Apr;62(4):372-380. doi: 10.1080/0284186X.2023.2199940. Epub 2023 Apr 19. Acta Oncol. 2023. PMID: 37073813 Clinical Trial.
Osteoclasts directly influence castration-resistant prostate cancer cells.
Huang J, Freyhult E, Buckland R, Josefsson A, Damber JE, Welén K. Huang J, et al. Among authors: damber je. Clin Exp Metastasis. 2022 Oct;39(5):801-814. doi: 10.1007/s10585-022-10179-2. Epub 2022 Aug 16. Clin Exp Metastasis. 2022. PMID: 35971022 Free PMC article.
Androgens, aging, and prostate health.
Welén K, Damber JE. Welén K, et al. Among authors: damber je. Rev Endocr Metab Disord. 2022 Dec;23(6):1221-1231. doi: 10.1007/s11154-022-09730-z. Epub 2022 Jun 24. Rev Endocr Metab Disord. 2022. PMID: 35748976 Free PMC article. Review.
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
Timing of the Pubertal Growth Spurt and Prostate Cancer.
Célind J, Bygdell M, Martikainen J, Styrke J, Damber JE, Kindblom JM, Ohlsson C. Célind J, et al. Among authors: damber je. Cancers (Basel). 2021 Dec 12;13(24):6238. doi: 10.3390/cancers13246238. Cancers (Basel). 2021. PMID: 34944857 Free PMC article.
Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C.
Thysell E, Köhn L, Semenas J, Järemo H, Freyhult E, Lundholm M, Thellenberg Karlsson C, Damber JE, Widmark A, Crnalic S, Josefsson A, Welén K, Nilsson RJA, Bergh A, Wikström P. Thysell E, et al. Among authors: damber je. Mol Oncol. 2022 Feb;16(4):846-859. doi: 10.1002/1878-0261.13158. Epub 2021 Dec 27. Mol Oncol. 2022. PMID: 34889043 Free PMC article.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
357 results